June 30

UCLA’s Course on Aging for Freshmen

April Pearce is in the middle of her freshman year at UCLA, settling into life away from home for the first time. But instead of thinking about dorm food or exams, the 19-year-old is focused on something a little more abstract: old age. That’s because of a unique course Pearce is taking called Frontiers in Human Aging, designed to teach first-year college students what it means to get old — physically, emotionally and financially. Pearce said that before, she barely noticed elderly people when she passed them on the street. Since being in the aging class, seeing them fills her mind with questions: Do they live alone? Will they develop dementia? Do they interact with anyone apart from relatives?” It’s weird, I know,” she said. “But before, I didn’t have any knowledge really about aging. I didn’t even interact with any older people except for my grandmother. Now I’m learning so much.” In addition to teaching students about aging, the professors have another goal in mind: inspiring them to pursue careers working with the elderly.

With more than 10,000 baby boomers turning 65 every day, there is a growing need, said Rita Effros, a professor at UCLA’s David Geffen School of Medicine who teaches both undergraduates and medical students. Throughout the year, students hear lectures about anxiety, genetics and dementia. They discuss ageism and read about Social Security. They stage debates on assisted suicide and watch films about growing old. The course lasts from September to June, and students can go on to take other classes about aging, including ones that focus on diversity or public policy.

For the article from the CNN, click here.

September 14

Common medications for dementia could cause harmful weight loss

Medications commonly used to treat dementia could result in harmful weight loss, according to UC San Francisco researchers, and clinicians need to account for this risk when prescribing these drugs to older adults, they said. Their study appears online and in the August issue of the Journal of the American Geriatrics Society. “This is very relevant to patient care because unintentional weight loss in older adults is associated with many adverse outcomes, including increased rates of institutionalization and mortality, a decline in functional status, and poorer quality of life,” said lead author Meera Sheffrin, MD, geriatrics fellow in the University of California San Francisco (UCSF) School of Medicine at the UCSF-affiliated San Francisco VA Medical Center. “Our study provides evidence in a large, real-world population that cholinesterase inhibitors may contribute to clinically significant weight loss in a substantial proportion of older adults with dementia.” Weight loss also is a significant problem in dementia patients and linked to increased mortality. Data from randomized controlled trials suggests this weight loss may be an under-recognized side effect of cholinesterase inhibitors, but evidence is limited and conflicting.

For the article from EurekAlert, click here.

June 4

Vietnam Vets’ Nightmares Offer Key to Dementia

For decades, dementia-causing conditions like Alzheimer’s were a mystery, illnesses that couldn’t be diagnosed for sure except at post-mortem. The development of advanced PET scans, combined with new tracer dyes means that doctors can now follow subtle biological routes in the brain and spinal fluid. That could explain how and why physical and psychological wartime traumas can double the risk of such conditions. “Vietnam Veterans are getting to an age now where we should be picking up changes in those people who are going to develop Alzheimer’s,” said Christopher Rowe, Director of Molecular Imaging Research at the Austin Hospital in Melbourne, who is leading the Australian arm of the research. The findings will offer insights into what causes dementia, cases of which are projected to almost double every 20 years. They could shed light on the long-term effects of assaults on the brain — whether sustained in battle, in a car wreck or on the football field, said Michael Weiner, professor of radiology at the University of California, San Francisco School of Medicine, who’s leading the study.

For the article from Bloomberg Business, click here.